| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7fd15d8ebb22202b5cfe2b109cd922c5 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6844 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate |
2014-12-15^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2015-07-23^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b49677a845243272aecf9a10c829533e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_72001d48d9a9759215dd8fbcddb04f91
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1ada52f30e40ed58b54f9c1d73bb1348
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a716e5c250d7a6af0357f4b5c18aa0ca |
| publicationDate |
2015-07-23^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-101539103-B1 |
| titleOfInvention |
Composition for predicting the response to anti-cancer drug of ovarian cancer using CpG methylation status in promoter region of MICAL2 gene and uses thereof |
| abstract |
The present invention relates to a composition, a kit and a method for predicting the anticancer drug response of ovarian cancer patients by detecting the methylation level of the CpG region of MICAL2 (microtubule associated monoxygenase, calponin and LIM domain containing 2) gene promoter. |
| priorityDate |
2014-12-15^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |